02/20/2025 22:30
IFF Announces Executive Leadership Team Aligned With New Operating Model

IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure. After 21 years of dedicated service to IFF, Simon Herriott, president of Health and Biosciences, will step down. Effective March 1, Leticia Gonçalves, ADM’s president of precision fermentation and ADM Ventures, will join IFF as president of Health and Biosciences. “Since 2019, Simon has driven growth and operational effectiveness through innovation, customer intimacy an...